title: Screening of JAK2 V617F and MPL W515 K/L negative essential thrombocythaemia patients for mutations in SESN2, DNAJC17, ST13, TOP1MT, and NTRK1.
authors.affiliation: Centre for Human Genetics, KU Leuven and University Hospital Leuven, Leuven, Belgium.
authors.forename: Carla
authors.initials: C
authors.lastname: Al Assaf
authors.forename: Els
authors.initials: E
authors.lastname: Lierman
authors.forename: Timothy
authors.initials: T
authors.lastname: Devos
authors.forename: Johan
authors.initials: J
authors.lastname: Billiet
authors.forename: Carlos
authors.initials: C
authors.lastname: Graux
authors.forename: Petros
authors.initials: P
authors.lastname: Papadopoulos
authors.forename: Peter
authors.initials: P
authors.lastname: Vandenberghe
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D008969:Molecular Sequence Data; D009154:Mutation; D053628:Receptors, Thrombopoietin / Q000235:genetics*; D016415:Sequence Alignment; D013920:Thrombocythemia, Essential / Q000235:genetics*
chemical_list: D053628:Receptors, Thrombopoietin; C082218:MPL protein, human; C507924:JAK2 protein, human; D053614:Janus Kinase 2
keywords: JAK2 V617F; TOP1MT; essential thrombocythaemia; in silico; mutations